Does low T cause hair loss? It is a question many people ask when they notice thinning hair alongside symptoms such as fatigue or reduced libido. Testosterone plays an important role in hair follicle biology, but the relationship between low testosterone and hair loss is more complex than it first appears. The hormone most closely linked to scalp hair loss is dihydrotestosterone (DHT), a potent derivative of testosterone — and low testosterone does not reliably reduce DHT or protect against hair thinning. This article explores the science behind testosterone and hair loss, other hormonal causes, when to seek medical advice, and the treatment options available in the UK.

How Testosterone Levels Affect Hair Growth and Loss

It is DHT — not testosterone directly — that binds to scalp follicle androgen receptors and causes the follicular miniaturisation underlying androgenetic alopecia; genetic predisposition determines individual sensitivity.

Testosterone is the primary male sex hormone, though it is also present in smaller amounts in women. It plays a wide-ranging role in the body, influencing muscle mass, bone density, mood, libido, and — importantly — hair growth. Understanding how testosterone interacts with hair follicles requires looking beyond the hormone itself and towards its more potent derivative: dihydrotestosterone (DHT).

Worried about interactions with other medications? Speak to one of our pharmacists →

DHT is produced when testosterone is converted by an enzyme called 5-alpha reductase. It is DHT, rather than testosterone directly, that binds to androgen receptors in hair follicles and can cause them to miniaturise — a process in which the follicle progressively produces finer, shorter hairs with each growth cycle (a shortened anagen phase), eventually producing vellus-like hairs. This is the primary mechanism behind androgenetic alopecia, commonly known as male or female pattern hair loss, and is strongly influenced by genetic predisposition. Further information is available from the NICE Clinical Knowledge Summary (CKS) on male and female pattern hair loss and from the British Association of Dermatologists (BAD) patient information on androgenetic alopecia.

It is worth noting that the relationship between testosterone, DHT, and hair loss is not straightforward. Hair follicles on the scalp respond differently to androgens than those on the face or body. Scalp follicles in genetically susceptible individuals are particularly sensitive to DHT, whereas beard and body hair follicles may actually be stimulated by the same hormone. This explains why some men with high androgen levels experience both significant scalp hair loss and robust beard growth simultaneously.

The Link Between Low Testosterone and Hair Thinning

Low testosterone is not a well-established primary cause of scalp hair loss; hypogonadism is more commonly associated with reduced body and facial hair than with androgenetic alopecia.

A common misconception is that low testosterone (low T) directly causes hair loss. In reality, the relationship is more nuanced. Because DHT — the hormone most closely associated with androgenetic alopecia — is derived from testosterone, it might seem logical that lower testosterone levels would reduce DHT and therefore protect against hair loss. However, this is not reliably the case, and there is no strong clinical evidence to suggest that low testosterone is a primary driver of scalp hair thinning in either sex.

Not sure if this is normal? Chat with one of our pharmacists →

In men, hypogonadism (clinically low testosterone) is more commonly associated with reduced body and facial hair, rather than scalp androgenetic alopecia. Some men with hypogonadism may notice diffuse changes in hair texture or density, but these effects are thought to relate to the broader metabolic and hormonal disruption that accompanies low T, rather than DHT-mediated follicular miniaturisation. The NHS and Society for Endocrinology UK provide guidance on the recognised features of male hypogonadism.

In women, hair changes around the menopause are more commonly driven by declining oestrogen levels than by low testosterone specifically. Androgen excess — for example in polycystic ovary syndrome (PCOS) — is a more established hormonal contributor to female pattern hair loss than low T. Low testosterone in women is not a well-established primary cause of scalp hair loss, and adrenal insufficiency more typically reduces axillary and pubic hair rather than causing scalp alopecia. NICE CKS guidance on menopause provides further context on hair changes in this period.

It is important to recognise that:

• Hair loss is multifactorial — testosterone is just one piece of the puzzle.

• Genetic predisposition plays a significant role in how hair follicles respond to hormonal changes.

• Low T alone is unlikely to be the sole cause of significant hair loss without other contributing factors.

If you are experiencing hair thinning alongside symptoms such as fatigue, low libido, or mood changes, it is worth discussing this with a GP, as these may collectively point to a hormonal imbalance.

Other Hormonal Causes of Hair Loss in Men and Women

Thyroid disorders, PCOS-related androgen excess, oestrogen deficiency post-menopause, and telogen effluvium are all recognised hormonal causes of hair loss that should be considered alongside testosterone.

Whilst testosterone and DHT receive considerable attention, several other hormonal conditions are well-established causes of hair loss and should not be overlooked. Identifying the correct underlying cause is essential for effective management.

Thyroid disorders are among the most common hormonal causes of diffuse hair loss. Both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) can disrupt the normal hair growth cycle, leading to shedding across the entire scalp. Thyroid function testing is a standard part of the investigation of unexplained hair loss in UK primary care, in line with NICE guidance on thyroid disease assessment.

Polycystic ovary syndrome (PCOS) is a common cause of androgen excess that can contribute to female pattern hair loss in genetically susceptible women. PCOS is associated with elevated androgen levels, including testosterone, which can trigger DHT-mediated follicular miniaturisation. Women with PCOS may also experience acne, irregular periods, and excess facial or body hair. It is important to note that many women with female pattern hair loss do not have PCOS; the two conditions can occur independently. NICE CKS guidance on PCOS provides further detail on diagnosis and management.

Telogen effluvium — a condition in which hair follicles are prematurely pushed into the resting phase, causing diffuse shedding — can be triggered by significant physiological or psychological stress, illness, surgery, or nutritional deficiency. Cushing's syndrome (chronic cortisol excess) is a rare but recognised cause; however, everyday stress-related hair shedding is multifactorial and should not be attributed solely to cortisol. NICE CKS covers telogen effluvium within its non-scarring alopecia guidance.

Elevated prolactin levels and insulin resistance have been associated with hair changes in some studies, though the evidence is largely associative rather than clearly causal, and these are not primary drivers of hair loss in most people.

Other relevant hormonal contributors include:

• Oestrogen deficiency — particularly post-menopause in women

• Adrenal androgen excess — such as in congenital adrenal hyperplasia (a rare condition)

• Growth hormone deficiency — which may affect hair texture and density, though this is uncommon

Non-hormonal causes — including postpartum telogen effluvium, iron deficiency, certain medications, and nutritional deficiencies — are also important and should be considered as part of a thorough clinical assessment. Because so many pathways can influence hair health, self-diagnosis is not advisable.

When to See a GP About Hair Loss and Low Testosterone

See a GP if hair loss is sudden, diffuse, patchy, or accompanied by symptoms such as fatigue, low libido, menstrual irregularities, or scalp inflammation, as these may indicate a treatable underlying cause.

Hair loss is extremely common and, in many cases, is a natural part of ageing. However, certain patterns or accompanying symptoms warrant a consultation with your GP to rule out an underlying medical cause.

You should consider booking an appointment if you notice:

• Sudden or rapid hair shedding, particularly in clumps or patches

• Diffuse thinning across the entire scalp rather than a gradual recession

• Hair loss accompanied by other symptoms such as fatigue, unexplained weight changes, cold intolerance, or low mood

• Symptoms that may suggest low testosterone, including reduced libido, erectile dysfunction, loss of muscle mass, or persistent tiredness

• Hair loss in women that is progressive or associated with menstrual irregularities, acne, or excess body hair

• Features of alopecia areata — well-defined patchy hair loss, which can affect the scalp, beard, or eyebrows

Seek prompt medical advice if you notice any of the following red-flag features, which may indicate scarring alopecia, tinea capitis (scalp ringworm), or another condition requiring expedited dermatology review:

• Scalp pain, redness, scaling, or pustules

• Broken hairs at the scalp surface or associated lymph node swelling (which may suggest tinea capitis)

• Rapidly progressive hair loss with scalp inflammation or scarring

It is also advisable to seek advice if hair loss is causing significant psychological distress. The impact of alopecia on mental health and wellbeing is well recognised, and GPs can refer patients to dermatology or endocrinology services where appropriate. Alopecia UK provides peer support and information for those affected.

Whilst there is no established direct link between mildly low testosterone and severe hair loss, the combination of hair thinning and other low-T symptoms is a reasonable trigger for investigation. Early diagnosis of conditions such as hypogonadism, thyroid disease, or PCOS can lead to effective treatment and may help slow or reverse hair loss in some cases. Do not delay seeking advice simply because hair loss seems cosmetic — it can be a meaningful indicator of broader health. Further guidance is available from the NHS hair loss (alopecia) page and NICE CKS topics on male and female pattern hair loss and alopecia areata.

Diagnosis and Testing: What the NHS Recommends

NHS-recommended investigations include at least two early-morning serum testosterone measurements, LH, FSH, SHBG, thyroid function tests, ferritin, and full blood count, tailored to the patient's sex and symptoms.

If a GP suspects a hormonal cause for hair loss, they will typically begin with a thorough clinical history and physical examination before requesting blood tests. The specific investigations ordered will depend on the presenting symptoms and the patient's sex and age.

For suspected low testosterone in men, the Society for Endocrinology UK and NHS guidance recommend measuring total serum testosterone on at least two separate occasions, ideally taken early in the morning (before 11am) when levels are at their peak. Additional tests may include:

• Luteinising hormone (LH) and follicle-stimulating hormone (FSH) — to distinguish between primary and secondary hypogonadism

• Sex hormone-binding globulin (SHBG) — to calculate free testosterone, particularly when total testosterone is borderline or SHBG is likely to be abnormal

• Prolactin — elevated levels can suppress testosterone production

For women presenting with hair loss where androgen excess is suspected (for example, in PCOS), investigations may include total testosterone, SHBG (to calculate the free androgen index), assessment of ovulatory function, and pelvic ultrasound where appropriate. The LH/FSH ratio is not recommended as a diagnostic criterion for PCOS under current UK guidance (NICE CKS – PCOS); diagnosis relies on clinical features, biochemistry, and ultrasound findings. Testing for DHEAS or other adrenal androgens is generally reserved for cases with marked virilisation or rapid-onset androgen excess.

In both sexes, a standard hair loss work-up will often also include:

• Full blood count (FBC) — to exclude anaemia

• Thyroid function tests (TFTs)

• Ferritin (iron stores) — low ferritin is a well-recognised cause of diffuse hair shedding

• Vitamin D and B12 levels — considered selectively, based on clinical suspicion or risk factors for deficiency, rather than as routine tests for all patients with hair loss

In cases of diagnostic uncertainty, a GP may refer to a dermatologist for trichoscopy or scalp biopsy to assess follicle health directly. NICE and NHS guidance supports a stepwise, evidence-based approach to investigation, avoiding unnecessary testing whilst ensuring treatable causes are not missed.

Treatment Options and Managing Hair Loss in the UK

Treatment depends on the underlying cause; licensed UK options for androgenetic alopecia include topical minoxidil for both sexes and finasteride 1 mg for men only, while TRT for hypogonadism may paradoxically worsen scalp hair loss by raising DHT.

Treatment for hair loss depends entirely on the underlying cause. Where a hormonal deficiency is identified and treated, hair loss may stabilise or partially reverse — though this is not guaranteed and results vary between individuals.

For low testosterone in men, testosterone replacement therapy (TRT) may be prescribed by a specialist following confirmed hypogonadism. TRT is available in several forms on the NHS, including gels, patches, and injections (see MHRA/EMC SmPCs for individual testosterone products such as Testogel and Nebido, and the BNF for prescribing information). It is important to note that TRT can increase DHT levels in some individuals, which may worsen androgenetic alopecia in those who are genetically predisposed. This risk should be discussed openly with the prescribing clinician as part of shared decision-making, and specialist review is advisable.

For androgenetic alopecia — the most common form of hair loss in both sexes — the following treatments are licensed and available in the UK:

• Topical minoxidil (available over the counter): a topical treatment that prolongs the hair growth phase. It is licensed for use in both men and women in the UK; licensed strengths differ by sex — refer to the MHRA/EMC SmPC and BNF for current indications and dosing.

• Finasteride 1 mg (prescription only, for men): a 5-alpha reductase inhibitor that reduces DHT production. Finasteride 1 mg is not indicated for use in women and is contraindicated in pregnancy due to the risk of feminisation of a male foetus. Any use in women would be off-label and should only be considered under specialist supervision. Refer to the MHRA/EMC SmPC for full safety information.

• Spironolactone: sometimes used off-label by specialists in women with androgen-related hair loss, particularly in PCOS. Important safety considerations include: effective contraception is required throughout treatment (spironolactone is teratogenic and carries anti-androgenic risk to a male foetus); it should be avoided in pregnancy; and potassium levels and renal function should be monitored regularly. Drug interactions should be reviewed before prescribing. Refer to the MHRA/EMC SmPC and BNF for full prescribing information.

For thyroid-related or nutritional hair loss, treating the root cause — whether with levothyroxine, iron supplementation, or vitamin D — often leads to meaningful hair regrowth over several months.

All medicines mentioned above are licensed in the UK by the MHRA; prescribing information is available via the EMC SmPC and the BNF. Patients are encouraged to have realistic expectations: hair regrowth is often gradual, and maintaining results typically requires ongoing treatment.

If you experience a suspected side effect from any medicine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Psychological support, including referral to counselling or peer support organisations such as Alopecia UK, can also be a valuable part of holistic care.

Frequently Asked Questions